[1]Effendi,Nurmaya;Ogawa,Kazuma;Mishiro,Kenji;Takarada,Takeshi;Yamada,Daisuke;Kitamura,Yoji;Shiba,Kazuhiro;Maeda,Takehiko;Odani,Akira[BioorganicandMedicinalChemistry,2017,vol.25,#20,p.5576-5585]
[1]Effendi,Nurmaya;Ogawa,Kazuma;Mishiro,Kenji;Takarada,Takeshi;Yamada,Daisuke;Kitamura,Yoji;Shiba,Kazuhiro;Maeda,Takehiko;Odani,Akira[BioorganicandMedicinalChemistry,2017,vol.25,#20,p.5576-5585]
[1]Effendi,Nurmaya;Ogawa,Kazuma;Mishiro,Kenji;Takarada,Takeshi;Yamada,Daisuke;Kitamura,Yoji;Shiba,Kazuhiro;Maeda,Takehiko;Odani,Akira[BioorganicandMedicinalChemistry,2017,vol.25,#20,p.5576-5585]
[1]Effendi,Nurmaya;Ogawa,Kazuma;Mishiro,Kenji;Takarada,Takeshi;Yamada,Daisuke;Kitamura,Yoji;Shiba,Kazuhiro;Maeda,Takehiko;Odani,Akira[BioorganicandMedicinalChemistry,2017,vol.25,#20,p.5576-5585]
[1]Effendi,Nurmaya;Ogawa,Kazuma;Mishiro,Kenji;Takarada,Takeshi;Yamada,Daisuke;Kitamura,Yoji;Shiba,Kazuhiro;Maeda,Takehiko;Odani,Akira[BioorganicandMedicinalChemistry,2017,vol.25,#20,p.5576-5585]
Title: Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy.
Journal: Clinical & experimental metastasis 20080101
Title: Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451.
Journal: Cancer research 20050201
Title: Xi Y, et al. CP-673451, a platelet-derived growth-factor receptor inhibitor, suppresses lung cancer cell proliferation and migration. Onco Targets Ther. 2014 Jul 3;7:1215-21.
Title: Konotop G, et al. Pharmacological Inhibition of Centrosome Clustering by Slingshot-Mediated Cofilin Activation and Actin Cortex Destabilization. Cancer Res. 2016 Nov 15;76(22):6690-6700.
Title: Ehnman M, et al. Distinct effects of ligand-induced PDGFRα and PDGFRβ signaling in the human rhabdomyosarcoma tumor cell and stroma cell compartments. Cancer Res, 2013, 73(7), 2139-2149.
Title: Roberts WG, et al. Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451. Cancer Res, 2005, 65(3), 957-966.
